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ABSTRACT 
 
Oxadiazoles are important five membered heterocyclic classes of compounds with 2 azo groups and 
one oxygen in its ring system. It is widely researched as a lead compound for designing potent bioactive 
agents. In this article we have reviewed on physical and chemical properties of oxadiazole, spectra and some 
methods for its synthesis. We have explored various pharmacological activities of oxadiazole derivatives like 
anti- inflammatory, anti-cancer, anti-fungal, anti-osteoporotic and anti-microbial. A brief on drugs containing 
oxadiazole ring and naturally occurring oxadiazole moiety have also been mentioned. 



































March – April  2015  RJPBCS   6(2)  Page No. 206 
INTRODUCTION 
 
Oxadiazole is a heterocyclic aromatic compound of molecular formula C2H2N2O. It is a five membered 
ring consisting of 2 nitrogen atoms, 2 carbon atoms, 1 oxygen atom and 2 double bonds. There are 4 isomers 














1, 2, 3 oxadiazole                           1, 2, 5 oxadiazole                          1, 3, 4 oxadiazole             1, 2, 4 oxadiazole 
(Diazo-oxides)                                (Furazan)                                   (Biazole)                           (Azoxime) 
 
 
The 1, 2, 3-isomer is unstable and reverts to the diazoketone tautomer [
1
].Oxadiazoles were 
discovered against the schistosomiasis-causing fluke in the year 2008. It did not show any negative effects on 
humans. The stable oxadiazoles appear in a variety of pharmaceutical drugs including raltegravir (anti-
retroviral), butalamine, fasiplon, oxolamine, and pleconaril. Tiodazosin, nosapidil, furamizole are other 
examples. The oxadiazoles were successfully tested against various diseases and hence are of importance in 
pharmaceutical chemistry due to their diverse medicinal potential. Nitrogen and oxygen containing 
compounds are always of synthetic interest. This is because there are large number of natural and synthetic 
compounds having nitrogen and oxygen with useful biological properties [2]. 
 
Literature survey reveals that the 1, 3, 4 oxadiazole undergoes a couple of reactions such as 
electrophilic substitution, nucleophilic substitution, thermal and photochemical reactions etc. Due to this 
reason it has been used in the preparation of 1, 3, 4 oxadiazole therapeutic molecules for various applications 
[3]. The compounds containing the 1,3, 4 oxadiazole nucleus was found to have unique anti-edema and anti-
inflammatory activities [4]. 
 
NATURALLY OCURRING OXADIAZOLES: 
 
 There are only few examples of natural products with oxadiazole core or a structure based on it. One 
among this is phidianidines A and B (Figure 1), this is a 3-substituted indole alkaloid. Phidianidines A and B 
have been isolated by Carbone et al. from the aeolid opisthobranch Phidiana militaris [5]. They selectively 
inhibits dopamine transporter DAT and also acts as partial agonists of the μ opioid receptor [6]. Phidianidine A 
and B do not have cytotoxic action and therefore it can be used as CNS targets. Quisqualic acid is another 
example for naturally occurring oxadiazole. (Figure 1). This is a metabolite which is obtained from the seeds of 
Quisqualis indica and Q. fructus .Quisqualic acid is a strong agonist for α-amino-3-hydroxy-5- methyl-4-

































Due to the presence of a heteroatom in the ring, oxadiazole shows inductive effect and thus it is 
considered to be a weak base. It consists of 2 pyridine like nitrogen, due to which it exhibits conjugate diene 
type character. Electrophillic substitution at carbon is very difficult in this case due to less electron density 
which is mainly due to the presence of pyridine like nitrogen in the ring that shows electron withdrawal effect. 
 
  Due to the presence of two pyridine type nitrogen, the aromaticity will be removed. Many studies on 
comparison between 1,2,4- and 1,3,4-oxadiazole pairs shows that ,in all cases,1,3,4-oxadiazole isomer shows 
lower magnitude lipophilicity (log D) as compared to its isomeric partner. Other differences involve metabolic 
stability, hERG inhibition, and aqueous solubility. All these studies favored the 1, 3, 4-oxadiazole isomers. The 
difference in profile between the 1, 2, 4 and 1, 3, 4 regioisomers can be rationalized by their intrinsically 
different charge distributions. 
 
Reactions with Electrophiles 
 
As mentioned above because of low electron density of carbon atom owing to the electron 
withdrawal by pyridine type nitrogen atom and also because of protonation possibility at nitrogen atom, the 
electrophilic substitution reactions are very difficult in oxadiazoles. Association with electron releasing groups 
in the ring can lead to electrophilic attack at nitrogen. No examples of nitration and sulphonation are yet found 















Reactions with Nucleophiles 
 
Oxadiazoles normally are resistant to nucleophilic substitution reactions except for halogen- 
substituted oxadiazoles. In this reaction halogen atom will be replaced by a nucleophile. Due to electron 
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Thermal and Photochemical Reactions 
 
Oxadiazoles, specifically 1, 3,4oxadiazoles are thermally stable. On substitution by aryl and 
perfluroalkyl groups the thermal stability of oxadiazole increases. When heated at high temperature (210 -





























Formation of Other Heterocyclic Ring Compounds 
 

















Physical Properties of 1,3,4 Oxadiazoles 
 
In 1955 the first monosubstituted 1,3,4-oxadiazoles were reported by two independent laboratories 
[8][9]. 1,3,4 oxadiazoles are liquid in nature. They have a boiling point of 150
0
 C [10-12].It does not have any 
freely rotating bonds. It has 3 hydrogen bond acceptors. Derivatives of 1,3,4 oxadiazoles like 2,5-disubstituted 























The IR spectra of 1,3,4-oxadiazole is characterized by bonds present at1640-1650 cm
-1 
(C=N) and at 
1020cm
-1 
(C=O) [13]. The position of both protons in 
1
H-NMR is 1.27.The refractive index n
25
D of 1,3,4-




It was first prepared in 1965 by Ainsworth. It was prepared using thermolysis of ethyl formate formyl 
hydrazone at atmospheric pressure [1]. 
 











By heating diacyl hydrazines with thionyl chloride (SOCl2) yields an oxadiazole [1]
































Kiselyov et al reported the synthesis of oxadiazole by refluxing isothiazole derivative with neat 
hydrazine hydrate for 4 hrs. The hydrazide so obtained can be further reacted with isothiocynates followed by 



















From N-Acyl Hydrazones 
 
Prakash et. al.; (2010); reported the synthesis of a series of novel 2,5-disubstituted 1,3,4-oxadiazole 




















From Acid Hydrazides 
 
The formation of 1,3,4 -oxadiazole via condensation of various alkyl hydrazides with substituted acids 
are reported in literature. A few of them are mentioned below. 
 
Husain et. al.; (2010); reported the synthesis of 1,3,4-Oxadiazole by reacting 4-oxo-4(biphenyl-4-















Fuloria et. al.; (2010); reported the synthesis of 1-(2aryl-5-phenethyl-1, 3, 4-oxadiazol-3(2H)-
yl)ethanones by reacting N-(substituted benzylidene)-3-phenyl propionohydrazides with acetic anhydride [18]. 
 
From Acetic Acid Hydrazides 
 
Kumar et. al.; (2010); reported the synthesis of 5-[(biphenyl-4-yloxy)-methyl]-2-substituted- 1,3,4-
oxadiazoles [Figure 8] by treatment of 2-(biphenyl-4-yloxy) acetic acid hydrazide with appropriate aromatic 
acid in presence of phosphorous oxychloride [19]. 
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Kamble et. al.; (2010); reported the microwave assisted synthesis of 1, 3, 4-oxadiazole from 
Chalcones. This microwave assisted synthesis lead to the cleaner reactions as well as afforded high yields and 
shorter reaction times. The chalcones underwent a rapid cyclisation with hydrazine hydrates using 
Polyethylene glycol (PEG 200) and formic acid as solvents. This Compound on bromination and heating with 




   Barbuceanu et. al.; (2010); reported the synthesis of oxadiazole by reacting N1-[4-(4-
bromophenylsulfonyl) benzoyl]-N4-(4-flourophenyl)-thiosemicarbazide with (a) Mercuric Oxide (HgO) in 
ethanol media (b) I2/KI in NaOH solution media [21].     
 
RCONHNH

































1. Asif Husain et al reported the synthesis of novel series of 2-[3-(4-bromophenyl)propan-3- one]-5-
(substituted phenyl)-1,3,4-oxadiazoles from 3-(4-bromobenzoyl) propionic acid with the aim to get 
better anti-inflammatory and analgesic agents with minimum or without side effects (ulcerogenicity). 
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Two compounds, 2-[3-(4- bromophenyl)- propan-3-one]-5-(4-chlorophenyl)- 1,3,4-oxadiazole  and 2-
[3-(4-bromophenyl)propan-3- one]-5-(3,4-dimethoxy phenyl)-1,3,4-oxadiazole with anti-inflammatory 
activity of 59.5 and 61.9 %, respectively, were found to have comparable activity with that of 









2. Harish Kumar et al reported a series of 1,3,4-oxadiazole and 1,2,4-triazole derivatives of biphenyl-4-
yloxy acetic acid and screened for anti-inflammatory activity, analgesic activity and lower ulcerogenic 
potential. All compounds were evaluated for their anti- inflammatory activity by the carrageenan 
induced rat paw edema test method. The Compound was evaluated as the lead compound having 
inflammatory activity (81.81%) than the reference drug (79.54%), it had low ulcerogenic potential and 








3. K. Manjunatha et al carried out the synthesis and evaluation of some 1,3,4-oxadiazole derivatives. 
They found that the compounds having 4- chlorophenylpiperazin-4-ylmethyl (5h) and 4- 












4. Trilok Chandra et al carried out the synthesis of substituted acridinyl pyrazoline derivatives. All the 
newly synthesized compounds were screened for their anti-inflammatory and analgesic activities. All 
the compounds have shown anti-inflammatory activity ranging from 10.8 to 40.8% at the dose of 50 
mg/kg, p.o. In addition of anti-inflammatory activity these compounds have also exhibited analgesic 
activity in the ranging from 8.6 to 33.5% at the dose of 50 mg/kg, i.p [25]. 
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1. A series of new 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety were synthesized by 
Qing-Zhong Zheng et al. Antiproliferative assay results indicated that compounds 6o and 6u exhibited 
the most potent activity against gastric cancer cell SGC-7901, which was more potent than the 
positive control. Especially, compound 6o exhibited significant telomerase inhibitory activity (IC50 = 
2.3 ± 0.07 lM), which was comparable to the positive control ethidium bromide. Docking simulation 
was performed to position compound 6o in to the active site of telomerase (3DU6) to determine the 









2. Alex S. Kiselyov et al carried out the design and synthesis of a series of novel 1,3,4-oxadiazole 
derivatives based on structural and electronic overlap with combretastatin A-2. It was tested in vivo 
using the sea urchin embryo development assay. The effect of these agents were monitored on two 
specific developmental stages of the embryo, namely i) fertilized egg to assess anti- mitotic activity; ii) 










Calcium Channel Blocker 
 
1. Girish R. BankaraIn investigated whether the correction of endothelial dysfunction is dependent on 
the normalization of high blood pressure levels by 1,3,4-oxadiazole derivative (NOX-1) in 
deoxycorticosterone acetate (DOCA-salt) and NG-nitro-l-arginine (L-NNA) hypertensive rats. In 
DOCA-salt and L-NNA hypertensive rats, the mean systolic blood pressure (MSBB) was 185.3±4.7 and 
170.2±4.1mmHg, whereas after administration of NOX-1 to hypertensive rats, MSBB was 127.8±4.5 
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Activity Against Snake Venom 
 
1. Ramya V. Shingalapur et al synthesized and evaluated a series of 1,3,4-oxadiazole-2 (3H)-thiones and 
1,3,4-thiadiazole-2 (3H)-thiones for their inhibitory activities against the two nucleotide  
pyrophosphates phosphodiesterase 1 enzymes. Dixon, as well as Lineweaver–Burk plots, and their 
secondary reports have indicated that the inhibition was of pure non-competitive type, against both 
snake venom and pure human recombinant enzymes as the Vmax values decreases without affecting 
the Km values. 5-[4-(t- Butyldimethylsilyloxy)- phenyl]-1,3,4-thiadiazole-2 (3H)-thione  and [4-(t-
butyldimethylsilyloxy)- phenyl]-1,3,4- oxadiazole-2 (3H)-thione  were found to be the most active 














1. Usman Ghani et al have prepared a series of cathepsin K inhibitors bearing the keto-1,3,4-oxadiazole 
warhead capable of forming a hemithioketal complex with the target enzyme. By modifying binding 
moieties at the P1, P2, and prime side positions of the inhibitors, selectivity over cathepsins B, L, and S 
are achieved and also sub-nanomolar potency against cathepsin K. This series thus represents a 
promising chemotype that could be used in diseases implicated by imbalances in cathepsin K activity 














1. G.C. Ramaprasad et al synthesized a series of novel 2-{4-[2-(5-ethylpyridin-2- yl)ethoxy]phenyl}-5-
substituted-1,3,4-oxadiazoles by the oxidative cyclisation of hydrazones derived from 4-[2-(5-
ethylpyridin-2-yl)ethoxy]benzaldehyde and arylhydrazines using chloramine-T as oxidant. IR, NMR and 
elemental analysis characterized the newly synthesized compounds. The synthesized compounds 
were evaluated for their antimicrobial activity and were compared with standard drugs. The 










2. Om Prakash et al carried out the hypervalent iodine (III) mediated synthesis of novel unsymmetrical 
2,5-disubstituted 1,3,4- oxadiazoles . The acid hydrazides derived from ibuprofen and 4-
methylthiophenyl acetic acids have been subjected to cyclization with carbon disulphide under basic 
ISSN: 0975-8585 
 
March – April  2015  RJPBCS   6(2)  Page No. 215 
conditions to yield 1,3,4-oxadiazol-2-thiones (3) which on aminomethylation with formaldehyde and 
secondary amines afforded a series of Mannich bases . Purity of the compounds has been confirmed 
by TLC. Structures of these compounds were established on the basis of elemental analyses and 
spectral studies. The newly synthesized compounds were evaluated for their anti-inflammatory, 












3. Keshari Kishore Jha et al synthesized some derivatives of benzimidazole by nucleophilic substitution of 
2- substituted-1H benzimidazole. The resulting ethyl (2- substituted-1H-benzimidazol-1-yl) acetate on 
treatment with hydrazine hydrate yielded 2-(2- substituted-1H-benzimidazol-1-yl) acetohydrazide, 
which on further reaction with one equivalent of different aliphatic or aromatic carboxylic acids in the 
presence of phosphoryl chloride afforded the corresponding target compounds, 2-substituted-1-[{(5- 
substitutedalkyl/aryl)-1,3,4-oxadiazol-2-yl} methyl]- 1H-benzimidazole. The structures of the 
synthesized compounds were evaluated by spectral and elemental methods of analyses. All the 
synthesized compounds were screened for their antimicrobial activities. All of the derivatives showed 
good activity towards Gram- positive bacteria and negligible activity towards Gram- negative bacteria. 












Drugs Containing Oxadiazole Moeity                                   
 







It is produced by Merck & Co. and received approval by U.S FDA on 12 October 2007, the first of a 
new class of integrase inhibitors to receive such approval.  
 
Mechanism: It targets the enzyme integrase which is used by the HIV to integrate the viral genetic material to 
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BUTALAMINE  (Vasodilator) 
 







                                                                                       
Fasiplon (Anti-Anxiety) 
   
IUPAC Name:  6-Ethyl-7-methoxy-5-methyl-2-(5-methyl-[1,2,4]oxadiazol-3-yl)-imidazo[1,2-a]pyrimidine 
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Pleconaril (Anti-Viral Drug) 
 
IUPAC Name: 3-{3,5-dimethyl-4-[3-(3-methylisoxazol-5-yl)propoxy] phenyl}-5-(trifluoromethyl)-1,2,4-
oxadiazole 
 
Mechanism: Pleconaril binds to a hydrophobic pocket in VP1, the major protein which comprises the capsid 
(the outer "shell") of picornaviruses. In enteroviruses, this prevents the virus from exposing its RNA, and in 
rhinoviruses it also prevents the virus from attaching itself to the host cell [36].   
 
Pleconaril was originally developed by Sanofi-Aventis and licensed to viropharma in 1997. Viro 
pharma developed it further developed and relicensed to Schering-plough in 2003. The phase 2 clinical trials 
were completed in 2007[37]. Results are yet to be reported. 
                                                                                                                     
Furamizole 
 












                                                                                                            
CONCLUSION 
 
This article deals about introduction of oxadiazole along with its basic chemistry and its physical and 
chemical properties. We further discuss about synthesis of oxadiazole and its substitutes. We also explore the 
common pharmacological properties and mention few of the currently used drugs of oxadiazole moiety. We 
are able to understand that oxadiazole is potential chemical with many useful properties and currently the 
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